. doi: 10.1016/j.virs.2026.03.002
Citation: Hongwei Zhao, Ju Yin, Yingdong Dong, Qianyu Feng, Huifang Liu, Shuaibing Han, Zhengde Xie, Lili Xu. Metatranscriptomics uncovers host immune and microbiome signatures specific to and shared between human metapneumovirus and respiratory syncytial virus infections in children .VIROLOGICA SINICA, 2026, 41(2) : 276-292.  http://dx.doi.org/10.1016/j.virs.2026.03.002

宏转录组学揭示儿童人偏肺病毒与呼吸道合胞病毒感染的特异性及共性宿主免疫与微生物组特征

  • 人偏肺病毒(hMPV)是一种在急性下呼吸道感染儿童中流行的呼吸道病毒,它与呼吸道合胞病毒(RSV)高度同源,RSV是儿童上呼吸道和下呼吸道感染的主要病原。虽然hMPV和RSV是肺炎病毒科中仅有的人类病原体且临床表现相似,但它们不同致病性的机制仍然知之甚少。在这项研究中,我们对2017年至2019年间收集的61名儿童(包括hMPV感染者、RSV感染者及健康对照组)的临床呼吸道样本进行了转录组学分析。分析揭示了抗病毒反应途径的共同上调,包括中性粒细胞激活和干扰素和白细胞介素介导的信号传导。相反,纤毛组织和组装途径在两种感染中普遍下调。hMPV感染独特地上调了与细胞外成分活性、离子通道复合物和神经活性配体-受体相互作用相关的途径。相反,与膜筏和膜微域相关的通路在hMPV感染患者中是唯一下调的。对差异表达的免疫相关基因和干扰素刺激基因的分析显示,EGF和FCGR1A显著增加,同时EPAS1表达降低。在hMPV感染过程中唯一上调的基因富集于细胞因子产生调节、细胞因子-细胞因子受体相互作用和PI3K/AKT信号传导,而那些唯一下调的基因涉及病毒进入和内吞囊泡途径。hMPV感染和RSV感染均显著增加了M1巨噬细胞和中性粒细胞的比例,而降低了M0和M2巨噬细胞的比例。值得注意的是,与RSV感染相比,hMPV感染导致单核细胞和活化NK细胞显著增加,同时静息记忆CD4+,T细胞减少。结果还显示,hMPV感染组唾液普氏菌的相对丰度显著高于RSV感染组,而唾液链球菌和唇炎链球菌的相对丰度显著高于RSV感染组。这些独特的免疫和微生物特征为儿童hMPV和RSV感染的发病机制提供了新的见解。

Metatranscriptomics uncovers host immune and microbiome signatures specific to and shared between human metapneumovirus and respiratory syncytial virus infections in children

  • Human metapneumovirus (hMPV) is a prevalent respiratory virus in children with acute lower respiratory tract infections that is highly homologous with respiratory syncytial virus (RSV), the primary etiological agent of pediatric upper and lower respiratory tract infections. Although hMPV and RSV are the only human pathogens within the Pneumoviridae family and share similar clinical manifestations, the mechanisms underlying their divergent pathogenicity remain poorly understood. In this study, we performed transcriptomic analysis on clinical respiratory samples collected between 2017 and 2019 from 61 children: including hMPV-infected, RSV-infected and healthy controls. This analysis revealed a shared upregulation of antiviral response pathways, including neutrophil activation and signaling mediated by interferons and interleukins. Conversely, cilium organization and assembly pathways were commonly downregulated in both infections. hMPV infection uniquely upregulated pathways associated with extracellular component activity, ion channel complexes, and neuroactive ligand‒receptor interactions. In contrast, pathways related to membrane rafts and membrane microdomains were uniquely downregulated in hMPV-infected patients. Analysis of differentially expressed immune-related and interferon-stimulated genes revealed significant hMPV-specific increases in EGF and FCGR1A, alongside decreased EPAS1 expression. The genes that were uniquely upregulated during hMPV infection were enriched in cytokine production regulation, cytokine-cytokine receptor interactions, and PI3K/AKT signaling, whereas those that were uniquely downregulated involved the viral entry and endocytic vesicle pathways. Both hMPV infection and RSV infection significantly increased the proportions of M1 macrophages and neutrophils but decreased the proportions of M0 and M2 macrophages. Notably, hMPV infection resulted in a significant increase in monocytes and activated NK cells coupled with a decrease in resting memory CD4+ T cells, compared with RSV infection. The results also revealed a significantly greater relative abundance of Prevotella salivae in the hMPV infection group, whereas Streptococcus salivarius and Streptococcus mitis were enriched in the RSV group. These distinct immune and microbial signatures provide novel insights into the pathogenesis of pediatric hMPV and RSV infections.

  • 加载中
    1. Allard B, Panariti A, Martin JG. 2018. Alveolar Macrophages in the Resolution of Inflammation, Tissue Repair, and Tolerance to Infection. Frontiers in Immunology, 9: 1777.

    2. Alvarez R, Harrod KS, Shieh W-J, Zaki S, Tripp RA. 2004. Human Metapneumovirus Persists in BALB/c Mice despite the Presence of Neutralizing Antibodies. Journal of Virology, 78: 14003-14011.

    3. Alvarez R, Tripp RA. 2005. The Immune Response to Human Metapneumovirus Is Associated with Aberrant Immunity and Impaired Virus Clearance in BALB/c Mice. Journal of Virology, 79: 5971-5978.

    4. Andrade CA, Pacheco GA, Galvez NMS, Soto JA, Bueno SM, Kalergis AM. 2020. Innate Immune Components That Regulate the Pathogenesis and Resolution of hRSV and hMPV Infections. Viruses, 12: 637.

    5. Arumugam M, Raes J, Pelletier E, Le Paslier D, Yamada T, Mende DR, Fernandes GR, Tap J, Bruls T, Batto J-M, Bertalan M, Borruel N, Casellas F, Fernandez L, Gautier L, Hansen T, Hattori M, Hayashi T, Kleerebezem M, Kurokawa K, Leclerc M, Levenez F, Manichanh C, Nielsen HB, Nielsen T, Pons N, Poulain J, Qin J, Sicheritz-Ponten T, Tims S, Torrents D, Ugarte E, Zoetendal EG, Wang J, Guarner F, Pedersen O, de Vos WM, Brunak S, Dore J, Weissenbach J, Ehrlich SD, Bork P. 2011. Enterotypes of the human gut microbiome. Nature, 473: 174-180.

    6. Ballegeer M, Saelens X. 2020. Cell-Mediated Responses to Human Metapneumovirus Infection. Viruses, 12: 542.

    7. Bataki EL, Evans GS, Everard ML. 2005. Respiratory syncytial virus and neutrophil activation. Clinical and Experimental Immunology, 140: 470-477.

    8. Battles MB, McLellan JS. 2019. Respiratory syncytial virus entry and how to block it. Nature Reviews Microbiology, 17: 233-245.

    9. Bibert S, Guex N, Lourenco J, Brahier T, Papadimitriou-Olivgeris M, Damonti L, Manuel O, Liechti R, Gotz L, Tschopp J, Quinodoz M, Vollenweider P, Pagani JL, Oddo M, Hugli O, Lamoth F, Erard V, Voide C, Delorenzi M, Rufer N, Candotti F, Rivolta C, Boillat-Blanco N, Bochud PY, Reg CSG. 2021. Transcriptomic Signature Differences Between SARS-CoV-2 and Influenza Virus Infected Patients. Front Immunol, 12: 666163.

    10. Bourgoin P, Biechele G, Ait Belkacem I, Morange PE, Malergue F. 2020. Role of the interferons in CD64 and CD169 expressions in whole blood: Relevance in the balance between viral- or bacterial-oriented immune responses. Immun Inflamm Dis, 8: 106-123.

    11. Bourgoin P, Soliveres T, Barbaresi A, Loundou A, Belkacem IA, Arnoux I, Bernot D, Loosveld M, Morange PE, Michelet P, Malergue F, Markarian T. 2021. CD169 and CD64 could help differentiate bacterial from CoVID-19 or other viral infections in the Emergency Department. Cytometry A, 99: 435-445.

    12. Bradley ES, Zeamer AL, Bucci V, Cincotta L, Salive M-C, Dutta P, Mutaawe S, Anya O, Tocci C, Moormann A, Ward DV, McCormick BA, Haran JP. 2022. Oropharyngeal microbiome profiled at admission is predictive of the need for respiratory support among COVID-19 patients. Frontiers in Microbiology, 13: 1009440.

    13. Carlin CR. 2022. Role of EGF Receptor Regulatory Networks in the Host Response to Viral Infections. Frontiers in Cellular and Infection Microbiology, 11: 820355.

    14. Chan LLY, Nicholls JM, Peiris JSM, Lau YL, Chan MCW, Chan RWY. 2020. Host DNA released by NETosis in neutrophils exposed to seasonal H1N1 and highly pathogenic H5N1 influenza viruses. Respiratory Research, 21: 160.

    15. Chapola H, de Bastiani MA, Duarte MM, Freitas MB, Schuster JS, de Vargas DM, Klamt F. 2023. A comparative study of COVID-19 transcriptional signatures between clinical samples and preclinical cell models in the search for disease master regulators and drug repositioning candidates. Virus Res, 326: 199053.

    16. Chatterjee S, Luthra P, Esaulova E, Agapov E, Yen BC, Borek DM, Edwards MR, Mittal A, Jordan DS, Ramanan P, Moore ML, Pappu RV, Holtzman MJ, Artyomov MN, Basler CF, Amarasinghe GK, Leung DW. 2017. Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses. Nature Microbiology, 2: 17101.

    17. Chen B, Khodadoust MS, Liu CL, Newman AM, Alizadeh AA. 2018a. Profiling tumor infiltrating immune cells with CIBERSORT. In: Cancer Systems Biology: Methods and Protocols. Springer, pp. 243-259.

    18. Chen S, Zhou Y, Chen Y, Gu J. 2018b. fastp: an ultra-fast all-in-one FASTQ preprocessor. Bioinformatics, 34: i884-i890.

    19. Chilvers MA, O’Callaghan C. 2000. Local mucociliary defence mechanisms. Paediatric Respiratory Reviews, 1: 27-34.

    20. Cortjens B, de Boer OJ, de Jong R, Antonis AFG, Pineros YSS, Lutter R, van Woensel JBM, Bem RA. 2016. Neutrophil extracellular traps cause airway obstruction during respiratory syncytial virus disease. Journal of Pathology, 238: 401-411.

    21. Darniot M, Pitoiset C, Petrella T, Aho S, Pothier P, Manoha C. 2009. Age-Associated Aggravation of Clinical Disease after Primary Metapneumovirus Infection of BALB/c Mice. Journal of Virology, 83: 3323-3332.

    22. de Steenhuijsen Piters WAA, Heinonen S, Hasrat R, Bunsow E, Smith B, Suarez-Arrabal M-C, Chaussabel D, Cohen DM, Sanders EAM, Ramilo O, Bogaert D, Mejias A. 2016. Nasopharyngeal Microbiota, Host Transcriptome, and Disease Severity in Children with Respiratory Syncytial Virus Infection. American Journal of Respiratory and Critical Care Medicine, 194: 1104-1115.

    23. Eichinger KM, Egana L, Orend JG, Resetar E, Anderson KB, Patel R, Empey KM. 2015. Alveolar macrophages support interferon gamma-mediated viral clearance in RSV-infected neonatal mice. Respiratory Research, 16: 122.

    24. Failler M, Giro-Perafita A, Owa M, Srivastava S, Yun C, Kahler DJ, Unutmaz D, Esteva FJ, Sanchez I, Dynlacht BD, Ginsberg M. 2021. Whole-genome screen identifies diverse pathways that negatively regulate ciliogenesis. Molecular Biology of the Cell, 32: 169-185.

    25. Feng Q, Feng Z, Yang B, Han S, Wen S, Lu G, Jin R, Xu B, Zhang H, Xu L, Xie Z. 2023a. Metatranscriptome Reveals Specific Immune and Microbial Signatures of Respiratory Syncytial Virus Infection in Children. Microbiol Spectr, 11: e0410722.

    26. Fiore-Gartland A, Panoskaltsis-Mortari A, Agan AA, Mistry AJ, Thomas PG, Matthay MA, Investigators PP, Hertz T, Randolph AG. 2017. Cytokine Profiles of Severe Influenza Virus-Related Complications in Children. Front Immunol, 8: 1423.

    27. Fjaertoft G, Pauksen K, Hakansson L, Xu S, Venge P. 2005. Cell surface expression of FcgammaRI (CD64) on neutrophils and monocytes in patients with influenza A, with and without complications. Scand J Infect Dis, 37: 882-889.

    28. Fujita A, Kan-o K, Tonai K, Yamamoto N, Ogawa T, Fukuyama S, Nakanishi Y, Matsumoto K. 2020. Inhibition of PI3Kδ Enhances Poly I:C-Induced Antiviral Responses and Inhibits Replication of Human Metapneumovirus in Murine Lungs and Human Bronchial Epithelial Cells. Frontiers in Immunology, 11: 432.

    29. Geiser J, Boivin G, Huang S, Constant S, Kaiser L, Tapparel C, Essaidi-Laziosi M. 2021. RSV and HMPV Infections in 3D Tissue Cultures: Mechanisms Involved in Virus-Host and Virus-Virus Interactions. Viruses, 13: 139.

    30. Goritzka M, Makris S, Kausar F, Durant LR, Pereira C, Kumagai Y, Culley FJ, Mack M, Akira S, Johansson C. 2015. Alveolar macrophage-derived type I interferons orchestrate innate immunity to RSV through recruitment of antiviral monocytes. Journal of Experimental Medicine, 212: 699-714.

    31. Hamelin M-Ev, Yim K, Kuhn KH, Cragin RP, Boukhvalova M, Blanco JCG, Prince GA, Boivin G. 2005. Pathogenesis of Human Metapneumovirus Lung Infection in BALB/c Mice and Cotton Rats. Journal of Virology, 79: 8894-8903.

    32. Han D, Liu C, Yang B, Yu F, Liu H, Lou B, Shen Y, Tang H, Zhou H, Zheng S, Chen Y. 2025. Metagenomic fingerprints in bronchoalveolar lavage differentiate pulmonary diseases. npj Digital Medicine, 8: 599.

    33. Haschka D, Petzer V, Burkert FR, Fritsche G, Wildner S, Bellmann-Weiler R, Tymoszuk P, Weiss G. 2022. Alterations of blood monocyte subset distribution and surface phenotype are linked to infection severity in COVID-19 inpatients. Eur J Immunol, 52: 1285-1296.

    34. He XY, Qian YB, Li ZG, Fan EK, Li YH, Wu L, Billiar TR, Wilson MA, Shi XY, Fan J. 2016. TLR4-Upregulated IL-1β and IL-1RI Promote Alveolar Macrophage Pyroptosis and Lung Inflammation through an Autocrine Mechanism. Scientific Reports, 6: 31663.

    35. Hong WQ, Yang JY, Zou J, Bi ZF, He C, Lei H, He XM, Li X, Alu AQ, Ren WY, Wang Z, Jiang XH, Zhong KH, Jia GW, Yang Y, Yu WH, Huang Q, Yang ML, Zhou YA, Zhao Y, Kuang DX, Wang JB, Wang HX, Chen SY, Luo M, Zhang ZQ, Lu TQ, Chen L, Que HY, He ZY, Sun Q, Wang W, Shen GB, Lu GW, Zhao ZW, Yang L, Yang JL, Wang ZL, Li J, Song XR, Dai LZ, Chen C, Geng J, Gou ML, Chen L, Dong HH, Peng Y, Huang CH, Qian ZY, Cheng W, Fan CF, Wei YQ, Su ZM, Tong AP, Lu SY, Peng XZ, Wei XW. 2022. Histones released by NETosis enhance the infectivity of SARS-CoV-2 by bridging the spike protein subunit 2 and sialic acid on host cells. Cellular & Molecular Immunology, 19: 577-587.

    36. Hu M, Bogoyevitch MA, Jans DA. 2020. Impact of Respiratory Syncytial Virus Infection on Host Functions: Implications for Antiviral Strategies. Physiological Reviews, 100: 1527-1594.

    37. Huang X, Luo Y, Wang J, Zhang X, Chen L, Wu R, Xue Z, Gu H, Li D, Tang H, Qin H, Zhao D, Liu F. 2024. Integrative study of pulmonary microbiome, transcriptome and clinical outcomes in Mycoplasma pneumoniae pneumonia. Respir Res, 25: 35.

    38. Huck B, Neumann-Haefelin D, Schmitt-Graeff A, Weckmann M, Mattes J, Ehl S, Falcone V. 2007. Human metapneumovirus induces more severe disease and stronger innate immune response in BALB/c mice as compared with respiratory syncytial virus. Respiratory Research, 8: 6.

    39. Jayavelu ND, Benson B, dela Cruz PC, Powell WT, Rich LM, Vanderwall ER, Gates CR, Nagel AJ, White MP, Samanas NB, Whitfield K, Hallstrand TS, Ziegler SF, Altman MC, Debley JS. 2025. Transcriptomic Profiling of Bronchial Epithelium Reveals Dysregulated Interferon and Inflammatory Responses to Rhinovirus in Exacerbation-Prone Pediatric Asthma. bioRxiv: 1-70.

    40. Kahn JS. 2006. Epidemiology of Human Metapneumovirus. Clinical Microbiology Reviews, 19: 546-557.

    41. Karabudak S, Ari O, Durmaz B, Dal T, Basyigit T, Kalcioglu MT, Durmaz R. 2019. Analysis of the effect of smoking on the buccal microbiome using next-generation sequencing technology. Journal of Medical Microbiology, 68: 1148-1158.

    42. Kim D, Paggi JM, Park C, Bennett C, Salzberg SL. 2019. Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype. Nature Biotechnology, 37: 907-915.

    43. Kolli D, Gupta MR, Sbrana E, Velayutham TS, Chao H, Casola A, Garofalo RP. 2014. Alveolar Macrophages Contribute to the Pathogenesis of Human Metapneumovirus Infection while Protecting against Respiratory Syncytial Virus Infection. American Journal of Respiratory Cell and Molecular Biology, 51: 502-515.

    44. Kulasinghe A, Tan CW, Ribeiro Dos Santos Miggiolaro AF, Monkman J, SadeghiRad H, Bhuva DD, Motta Junior JDS, Busatta Vaz de Paula C, Nagashima S, Baena CP, Souza-Fonseca-Guimaraes P, de Noronha L, McCulloch T, Rossi GR, Cooper C, Tang B, Short KR, Davis MJ, Souza-Fonseca-Guimaraes F, Belz GT, O'Byrne K. 2022. Profiling of lung SARS-CoV-2 and influenza virus infection dissects virus-specific host responses and gene signatures. Eur Respir J, 59: 2101881.

    45. Larsen JM, Musavian HS, Butt TM, Ingvorsen C, Thysen AH, Brix S. 2015. Chronic obstructive pulmonary disease and asthma-associated Proteobacteria, but not commensal Prevotella spp., promote Toll-like receptor 2-independent lung inflammation and pathology. Immunology, 144: 333-342.

    46. Liao Y, Smyth GK, Shi W. 2014. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics, 30: 923-930.

    47. Liesman RM, Buchholz UJ, Luongo CL, Yang LJ, Proia AD, DeVincenzo JP, Collins PL, Pickles RJ. 2014. RSV-encoded NS2 promotes epithelial cell shedding and distal airway obstruction. Journal of Clinical Investigation, 124: 2219-2233.

    48. Lin Z, Jiang Y, Liu H, Yang J, Yang B, Zhang K, Tang P, Xiang B, Sun B. 2025. Airway microbiota and immunity associated with chronic obstructive pulmonary disease severity. Journal of Translational Medicine, 23: 962.

    49. Livak KJ, Schmittgen TD. 2001. Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2-ΔΔCT Method. Methods, 25: 402-408.

    50. Lo MS, Brazas RM, Holtzman MJ. 2005. Respiratory syncytial virus nonstructural proteins NS1 and NS2 mediate inhibition of Stat2 expression and alpha/beta interferon responsiveness. Journal of Virology, 79: 9315-9319.

    51. Love MI, Huber W, Anders S. 2014. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biology, 15: 550.

    52. Mall MA. 2008. Role of Cilia, Mucus, and Airway Surface Liquid in Mucociliary Dysfunction: Lessons from Mouse Models. Journal of Aerosol Medicine and Pulmonary Drug Delivery, 21: 13-24.

    53. McNamara PS, Ritson P, Selby A, Hart CA, Smyth RL. 2003. Bronchoalveolar lavage cellularity in infants with severe respiratory syncytial virus bronchiolitis. Archives of Disease in Childhood, 88: 922-926.

    54. Nam HH, Ison MG. 2019. Respiratory syncytial virus infection in adults. Bmj: l5021.

    55. Newman AM, Liu CL, Green MR, Gentles AJ, Feng W, Xu Y, Hoang CD, Diehn M, Alizadeh AA. 2015. Robust enumeration of cell subsets from tissue expression profiles. Nature Methods, 12: 453-457.

    56. Nicolas de Lamballerie C, Pizzorno A, Dubois J, Julien T, Padey B, Bouveret M, Traversier A, Legras-Lachuer C, Lina B, Boivin G, Terrier O, Rosa-Calatrava M. 2019. Characterization of cellular transcriptomic signatures induced by different respiratory viruses in human reconstituted airway epithelia. Scientific Reports, 9: 11493.

    57. Oksanen J, Blanchet FG, Kindt R, Legendre P, Minchin PR, O’hara R, Simpson GL, Solymos P, Stevens MHH, Wagner H. 2013. Package ‘vegan’. Community ecology package, version, 2: 1-295.

    58. Rajagopala SV, Bakhoum NG, Pakala SB, Shilts MH, Rosas-Salazar C, Mai A, Boone HH, McHenry R, Yooseph S, Halasa N, Das SR. 2021. Metatranscriptomics to characterize respiratory virome, microbiome, and host response directly from clinical samples. Cell Reports Methods, 1: 100091.

    59. Ren JP, Liu TS, Pang L, Li K, Garofalo RP, Casola A, Bao XY. 2011. A novel mechanism for the inhibition of interferon regulatory factor-3-dependent gene expression by human respiratory syncytial virus NS1 protein. Journal of General Virology, 92: 2153-2159.

    60. Ren L, Zhang R, Rao J, Xiao Y, Zhang Z, Yang B, Cao D, Zhong H, Ning P, Shang Y, Li M, Gao Z, Wang J, Jansson JK. 2018. Transcriptionally Active Lung Microbiome and Its Association with Bacterial Biomass and Host Inflammatory Status. mSystems, 3: e00199.

    61. Ren X, Wen W, Fan X, Hou W, Su B, Cai P, Li J, Liu Y, Tang F, Zhang F, Yang Y, He J, Ma W, He J, Wang P, Cao Q, Chen F, Chen Y, Cheng X, Deng G, Deng X, Ding W, Feng Y, Gan R, Guo C, Guo W, He S, Jiang C, Liang J, Li Y-m, Lin J, Ling Y, Liu H, Liu J, Liu N, Liu S-Q, Luo M, Ma Q, Song Q, Sun W, Wang G, Wang F, Wang Y, Wen X, Wu Q, Xu G, Xie X, Xiong X, Xing X, Xu H, Yin C, Yu D, Yu K, Yuan J, Zhang B, Zhang P, Zhang T, Zhao J, Zhao P, Zhou J, Zhou W, Zhong S, Zhong X, Zhang S, Zhu L, Zhu P, Zou B, Zou J, Zuo Z, Bai F, Huang X, Zhou P, Jiang Q, Huang Z, Bei J-X, Wei L, Bian X-W, Liu X, Cheng T, Li X, Zhao P, Wang F-S, Wang H, Su B, Zhang Z, Qu K, Wang X, Chen J, Jin R, Zhang Z. 2021. COVID-19 immune features revealed by a large-scale single-cell transcriptome atlas. Cell, 184: 1895-1913.e1819.

    62. Rima B, Collins P, Easton A, Fouchier R, Kurath G, Lamb RA, Lee B, Maisner A, Rota P, Wang L. 2017. ICTV Virus Taxonomy Profile: Pneumoviridae. Journal of General Virology, 98: 2912-2913.

    63. Rouka E, Hatzoglou C, Gourgoulianis KI, Zarogiannis SG. 2020. Interactome networks between the human respiratory syncytial virus (HRSV), the human metapneumovirus (ΗMPV), and their host: In silico investigation and comparative functional enrichment analysis. Microbial Pathogenesis, 141: 104000.

    64. Ruuskanen O, Lahti E, Jennings LC, Murdoch DR. 2011. Viral pneumonia. The Lancet, 377: 1264-1275.

    65. Schmitz N, Kurrer M, Bachmann MF, Kopf M. 2005. Interleukin-1 is responsible for acute lung immunopathology but increases survival of respiratory influenza virus infection. Journal of Virology, 79: 6441-6448.

    66. Schowalter RM, Chang A, Robach JG, Buchholz UJ, Dutch RE. 2009. Low-pH Triggering of Human Metapneumovirus Fusion: Essential Residues and Importance in Entry. Journal of Virology, 83: 1511-1522.

    67. Schuurhof A, Bont L, Hodemaekers HM, de Klerk A, de Groot H, Hofland RW, van de Pol AC, Kimpen JLL, Janssen R. 2012. Proteins involved in extracellular matrix dynamics are associated with respiratory syncytial virus disease severity. European Respiratory Journal, 39: 1475-1481.

    68. Soto JA, Galvez NMS, Benavente FM, Pizarro-Ortega MS, Lay MK, Riedel C, Bueno SM, Gonzalez PA, Kalergis AM. 2018. Human Metapneumovirus: Mechanisms and Molecular Targets Used by the Virus to Avoid the Immune System. Frontiers in Immunology, 9: 2466.

    69. Spann KM, Tran KC, Collins PL. 2005. Effects of nonstructural proteins NS1 and NS2 of human respiratory syncytial virus on interferon regulatory factor 3, NF-κB, and proinflammatory cytokines. Journal of Virology, 79: 5353-5362.

    70. Steuerman Y, Cohen M, Peshes-Yaloz N, Valadarsky L, Cohn O, David E, Frishberg A, Mayo L, Bacharach E, Amit I, Gat-Viks I. 2018. Dissection of Influenza Infection In Vivo by Single-Cell RNA Sequencing. Cell Systems, 6: 679-691.e674.

    71. Swift ML. 1997. GraphPad prism, data analysis, and scientific graphing. Journal of chemical information and computer sciences, 37: 411-412.

    72. Thomas KW, Monick MM, Staber JM, Yarovinsky T, Carter AB, Hunninghake GW. 2002. Respiratory syncytial virus inhibits apoptosis and induces NF-κB activity through a phosphatidylinositol 3-kinase-dependent pathway. Journal of Biological Chemistry, 277: 492-501.

    73. Toussaint M, Jackson DJ, Swieboda D, Guedan A, Tsourouktsoglou T-D, Ching YM, Radermecker C, Makrinioti H, Aniscenko J, Bartlett NW, Edwards MR, Solari R, Farnir F, Papayannopoulos V, Bureau F, Marichal T, Johnston SL. 2017. Host DNA released by NETosis promotes rhinovirus-induced type-2 allergic asthma exacerbation. Nature Medicine, 23: 681-691.

    74. Treister A, Pico AR. 2018. Identifier Mapping in Cytoscape. F1000Research, 7: 725.

    75. Tsalik EL, Fiorino C, Aqeel A, Liu Y, Henao R, Ko ER, Burke TW, Reller ME, Bodinayake CK, Nagahawatte A, Arachchi WK, Devasiri V, Kurukulasooriya R, McClain MT, Woods CW, Ginsburg GS, Tillekeratne LG, Schughart K. 2021. The Host Response to Viral Infections Reveals Common and Virus-Specific Signatures in the Peripheral Blood. Frontiers in Immunology, 12: 741837.

    76. Tsang TK, Lee KH, Foxman B, Balmaseda A, Gresh L, Sanchez N, Ojeda S, Lopez R, Yang Y, Kuan G, Gordon A. 2020. Association Between the Respiratory Microbiome and Susceptibility to Influenza Virus Infection. Clinical Infectious Diseases, 71: 1195-1203.

    77. van den Hoogen BG, de Jong JC, Groen J, Kuiken T, de Groot R, Fouchier RAM, Osterhaus ADME. 2001. A newly discovered human pneumovirus isolated from young children with respiratory tract disease. Nature Medicine, 7: 719-724.

    78. Vivier E, Tomasello E, Baratin M, Walzer T, Ugolini S. 2008. Functions of natural killer cells. Nature Immunology, 9: 503-510.

    79. von Mering C, Friedman J, Alm EJ. 2012. Inferring Correlation Networks from Genomic Survey Data. PLoS Computational Biology, 8: e1002687.

    80. Wang N, Hua J, Fu Y, An J, Chen X, Wang C, Zheng Y, Wang F, Ji Y, Li Q. 2023. Updated perspective of EPAS1 and the role in pulmonary hypertension. Front Cell Dev Biol, 11: 1125723.

    81. Wang S, Yao X, Ma S, Ping Y, Fan Y, Sun S, He Z, Shi Y, Sun L, Xiao S, Song M, Cai J, Li J, Tang R, Zhao L, Wang C, Wang Q, Zhao L, Hu H, Liu X, Sun G, Chen L, Pan G, Chen H, Li Q, Zhang P, Xu Y, Feng H, Zhao G-G, Wen T, Yang Y, Huang X, Li W, Liu Z, Wang H, Wu H, Hu B, Ren Y, Zhou Q, Qu J, Zhang W, Liu G-H, Bian X-W. 2021. A single-cell transcriptomic landscape of the lungs of patients with COVID-19. Nature Cell Biology, 23: 1314-1328.

    82. Wen SC, Tollefson SJ, Johnson M, Gilchuk P, Boyd KL, Shepherd B, Joyce S, Williams JV. 2014. Acute clearance of human metapneumovirus occurs independently of natural killer cells. J Virol, 88: 10963-10969.

    83. Whelan JN, Tran KC, van Rossum DB, Teng MN. 2016. Identification of Respiratory Syncytial Virus Nonstructural Protein 2 Residues Essential for Exploitation of the Host Ubiquitin System and Inhibition of Innate Immune Responses. Journal of Virology, 90: 6453-6463.

    84. Wood DE, Lu J, Langmead B. 2019. Improved metagenomic analysis with Kraken 2. Genome Biology, 20: 257.

    85. Wu X, Dao Thi VL, Huang Y, Billerbeck E, Saha D, Hoffmann H-H, Wang Y, Silva LAV, Sarbanes S, Sun T, Andrus L, Yu Y, Quirk C, Li M, MacDonald MR, Schneider WM, An X, Rosenberg BR, Rice CM. 2018. Intrinsic Immunity Shapes Viral Resistance of Stem Cells. Cell, 172: 423-438.e425.

    86. Yildiz Gulhan P, Eroz R, Ozturk CE, Yekenkurul D, Altinsoy HB, Gulec Balbay E, Ercelik M, Davran F, Yildiz S. 2025. Determination of both the expression and serum levels of epidermal growth factor and transforming growth factor beta1 genes in COVID-19. Sci Rep, 15: 9771.

    87. Yu G, Wang L-G, Han Y, He Q-Y. 2012. clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters. OMICS: A Journal of Integrative Biology, 16: 284-287.

    88. Zhang RY, Sun C, Han YZ, Huang L, Sheng HH, Wang J, Zhang YQ, Lai J, Yuan JH, Chen XM, Jiang C, Wu FY, Wang JM, Fan XC, Wang J. 2023. Neutrophil autophagy and NETosis in COVID-19: perspectives. Autophagy, 19: 758-767.

    89. Zhu Y, Luo Y, Li L, Jiang X, Du Y, Wang J, Li H, Gu H, Li D, Tang H, Qin H, Xu C, Liu Y, Zhao D, Guo Y, Liu F. 2023. Immune response plays a role in Mycoplasma pneumoniae pneumonia. Front Immunol, 14: 1189647.

  • 加载中
  • 10.1016j.virs.2026.03.002-ESM6.xlsx
    10.1016j.virs.2026.03.002-ESM9.xlsx
    10.1016j.virs.2026.03.002-ESM4.xlsx
    10.1016j.virs.2026.03.002-ESM2.xlsx
    10.1016j.virs.2026.03.002-ESM7.xlsx
    10.1016j.virs.2026.03.002-ESM1.docx
    10.1016j.virs.2026.03.002-ESM10.xlsx
    10.1016j.virs.2026.03.002-ESM3.xlsx
    10.1016j.virs.2026.03.002-ESM8.xlsx
    10.1016j.virs.2026.03.002-ESM5.xlsx

Figures(1)

Article Metrics

Article views(2173) PDF downloads(36) Cited by(0)

Related
Proportional views
    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Metatranscriptomics uncovers host immune and microbiome signatures specific to and shared between human metapneumovirus and respiratory syncytial virus infections in children

      Corresponding author: Zhengde Xie, xiezhengde@bch.com.cn
      Corresponding author: Lili Xu, justinexull26@163.com
    • a. Beijing Key Laboratory of Core Technologies for the Prevention and Treatment of Emerging Infectious Diseases in Children, National Clinical Research Center for Respiratory Diseases, National Key Discipline of Pediatrics (Capital Medical University), Beijing Research Center for Respiratory Infectious Diseases, Beijing Pediatric Research Institute, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing 100045, China;
    • b. Research Unit of Critical Infection in Children, Chinese Academy of Medical Sciences, 2019RU016, Beijing 100045, China;
    • c. Department of Respiratory, National Clinical Research Center for Respiratory Diseases, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing 100045, China;
    • d. Vision Medical Center for Infectious Diseases, Guangzhou 510300, China

    Abstract: Human metapneumovirus (hMPV) is a prevalent respiratory virus in children with acute lower respiratory tract infections that is highly homologous with respiratory syncytial virus (RSV), the primary etiological agent of pediatric upper and lower respiratory tract infections. Although hMPV and RSV are the only human pathogens within the Pneumoviridae family and share similar clinical manifestations, the mechanisms underlying their divergent pathogenicity remain poorly understood. In this study, we performed transcriptomic analysis on clinical respiratory samples collected between 2017 and 2019 from 61 children: including hMPV-infected, RSV-infected and healthy controls. This analysis revealed a shared upregulation of antiviral response pathways, including neutrophil activation and signaling mediated by interferons and interleukins. Conversely, cilium organization and assembly pathways were commonly downregulated in both infections. hMPV infection uniquely upregulated pathways associated with extracellular component activity, ion channel complexes, and neuroactive ligand‒receptor interactions. In contrast, pathways related to membrane rafts and membrane microdomains were uniquely downregulated in hMPV-infected patients. Analysis of differentially expressed immune-related and interferon-stimulated genes revealed significant hMPV-specific increases in EGF and FCGR1A, alongside decreased EPAS1 expression. The genes that were uniquely upregulated during hMPV infection were enriched in cytokine production regulation, cytokine-cytokine receptor interactions, and PI3K/AKT signaling, whereas those that were uniquely downregulated involved the viral entry and endocytic vesicle pathways. Both hMPV infection and RSV infection significantly increased the proportions of M1 macrophages and neutrophils but decreased the proportions of M0 and M2 macrophages. Notably, hMPV infection resulted in a significant increase in monocytes and activated NK cells coupled with a decrease in resting memory CD4+ T cells, compared with RSV infection. The results also revealed a significantly greater relative abundance of Prevotella salivae in the hMPV infection group, whereas Streptococcus salivarius and Streptococcus mitis were enriched in the RSV group. These distinct immune and microbial signatures provide novel insights into the pathogenesis of pediatric hMPV and RSV infections.

    Figure (1)  Reference (89) Relative (20)

    目录

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return